Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PSA (prostate specific antigen) tests to be reimbursed in Germany

This article was originally published in Clinica

Executive Summary

A decision by the German Upper House (Bundesrat) to approve prostate specific antigen (PSA) tests, used to diagnose prostate cancer, for reimbursement by the statutory health insurance funds, has been welcomed by the diagnostics industry association, VDGH. "This is the first concrete indication of politicians paying more than lip service to promises that the early detection of illness should play a more important role in the health service," said VDGH chairman Dierk Meyer-Luerbetaen.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061518

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel